Neurovascular Compression Associated with Trigeminal Neuralgia and Systemic Arterial Hypertension: Surgical TreatmentSendeski M. · Aguiar P.H. · Zanetti M.V. · Teixeira M.J. · Cescato V.Â.
Clínica Neurocirúrgica Pinheiros, São Paulo, Brazil
Do you have an account?
- Rent for 48h to view
- Buy Cloud Access for unlimited viewing via different devices
- Synchronizing in the ReadCube Cloud
- Printing and saving restrictions apply
Rental: USD 8.50
Cloud: USD 20.00
Objective and Importance: To highlight arterial hypertension as an additional factor favoring surgical indication in neurovascular compression syndromes such as trigeminal neuralgia, hemifacial spasm, and glossopharyngeal neuralgia. Clinical Presentation: A 52-year-old woman with trigeminal neuralgia concomitant with systemic arterial hypertension, submitted initially to unsatisfactory conservative treatment, presents tortuousness and enlargement of the vertebral artery (VA) topography on magnetic resonance imaging (MRI). A microsurgical neurovascular decompression of the trigeminal nerve and the medulla was performed, revealing that the compression was due to the superior cerebellar artery instead of the VA. Both the neuralgia and the hypertension were controlled with no need of medication during a 1-year follow-up. Conclusion: Surgical indication in neurovascular compression disorders should be reinforced in the presence of concomitant arterial hypertension and a compatible MRI examination.
© 2002 S. Karger AG, Basel
- Janneta P: Neurovascular compression in cranial nerve and systemic disease. Ann Surg 1980;192:518–525.
- Wilkins RH: Neurovascular compression syndromes. Neurol Clin 1985;3:359–372.
- Jannetta PJ, Gendell HM: Clinical observations on the etiology of essential hypertension. Surg Forum 1979;30:431–432.
- Naraghi R, Geiger H, Crnac J, Huk W, Falhbush R, Engels G, Luft FC: Posterior fossa neurovascular anomalies in essential hypertension. Lancet 1994;344:1466–1470.
- Akimura T, Furutani Y, Jimi Y, Saito K, Kashiwagi S, Kato S, Ito H: Essential hypertension and neurovascular compression at the ventrolateral medulla oblongata: MR evaluation. AJNR Am J Neuroradiol 1995;16:401–405.
- Pierpaolo L, Mastronardi L, Strano S, Di Biasi C, Trasimeni G: Neurovascular conflict and essential hypertension: MR evaluation. AJNR Am J Neuroradiol 1996;17:195.
- Kleineberg B, Becker H, Gaab MR: Neurovascular compression and essential hypertension. An angiographic study. Neuroradiology 1991;33:2–8.
- Naraghi R, Gaab M, Walter GF, Kleineberg B: Arterial hypertension and neurovascular compression at the ventrolateral medulla. A comparative microanatomical and pathological study. J Neurosurg 1992;77:103–112.
Saglitz AS, Gaab MR, Assaf J, Naraghi R, Kleineberg B: Neurovascular compression at the left ventrolateral medulla as an etiologic factor for arterial hypertension. Exp Clin Endocrinol Diabetes 1997;105(suppl 2):9–11.
- Morimoto S, Sasaki S, Miki S, Kawa T, Itoh H, Nakata T, Takeda K, Nakagawa M, Naruse S, Maeda T: Pulsatile compression of the rostral ventrolateral medulla in hypertension. Hypertension 1997;29:514–518.
- Morimoto S, Sasaki S, Takeda K, Furuya S, Naruse S, Matsumoto K, Higuchi T, Saito M, Nakagawa M: Decreases in blood pressure and sympathetic nerve activity by microvascular decompression of the rostral ventrolateral medulla in essential hypertension. Stroke 1999;30:1707–1710.
- Makino Y, Kawano Y, Okuda N, Horio T, Iwashima Y, Yamada N, Takamiya M, Takishita S: Autonomic function in hypertensive patients with neurovascular compression of the ventrolateral medulla oblongata. J Hypertens 1999;17:1257–1263.
- Janneta P, Segal R, Wolfson SK Jr: Neurogenic hypertension: Etiology and surgical treatment. I. Observation in 53 patients. Ann Surg 1985;201:391–398.
- Jannetta P, Segal R, Wolfson SK Jr, Dujovny M, Semba A, Cook EE: Neurogenic hypertension: Etiology and surgical treatment. II. Observation in an experimental nonhuman primate model. Ann Surg 1985;202:253–262.
- Kleineberg B, Becker H, Gaab M, Naraghi R: Essential hypertension associated with neurovascular compression: Angiographic findings. Neurosurgery 1992;30:834–841.
- Watters MR, Burton BS, Turner GE, Cannard KR: MR screening for brain stem compression in hypertension. AJNR Am J Neuroradiol 1996;17:217–221.
- Colon GP, Quint DJ, Dickinson LD, Brunberg JA, Jamerson KA, Hoff JT, Ross DR: Magnetic resonance evaluation of ventrolateral medullary compression in essential hypertension. J Neurosurg 1998;88:226–231.
- Levy EI, Clyde BC, Mclaughlin MR, Jannetta PJ: Microvascular decompression of the ventrolateral medulla oblongata for severe refractory neurogenic hypertension. Neurosurgery 1998;43:1–9.
- Geiger H, Naraghi R, Schobel HP, Frank H, Sterzel RB, Fahlbusch R: Decrease of blood pressure by ventrolateral medullary decompression in essential hypertension. Lancet 1998;352:446–449.
Anding K, Bloss HG, Krummer B, Schwabe M, Geiger H, Schollmeyer P, Rump LC: Neurovascular decompression of the ventrolateral medulla as a treatment of hypertension in a patient with renal artery stenosis. Nephrol Dial Transplant 1998;13:3253–3257.
Kiely JM, Gordon FJ: Role of rostral ventrolateral medulla in centrally mediated pressor responses. Am J Physiol 1994;267:H1549–H1556.
- Chalmers J, Pilowsky P: Brainstem and bulbospinal neurotransmitter systems in the control of blood pressure. J Hypertens 1991;9:675–694.
- Morimoto S, Sasaki S, Kawa T, Nakamura K, Ichida T, Itoh H, Nakata T, Takeda K, Nakagawa M, Yamada H: Pressor responses to compression of the ventrolateral medulla mediated by glutamate receptors. Hypertension 1999;33:1207–1213.
Article / Publication Details
Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.